The Global Genetic Testing Market is poised to grow at a CAGR of around 10.4% over the next decade to reach approximately $10.3 billion by 2025. Some of the prominent trends that the market is witnessing include increasing prevalence of infectious, chronic, and genetic diseases, rising market for personalized medicine, and encouraging legislative & regulatory policies.
On basis of test type the market is segmented by predictive & presymptomatic testing, diagnostic testing, carrier testing, prenatal testing, and new born screening.
By diseases the market is classified into thalassemia, sickle cell anemia, alzheimer's diseases, duchenne's muscular dystrophy, huntington’s disease, cancer, cystic fibrosis, and other diseases.
Depending on the technology the market is segregated molecular testing, cytogenetic testing, and biochemical testing.
Based on application the market is categorized into cancer genetic testing, prenatal genetic testing, filling and capping machinery, pharmacogenomics genetic testing, and predisposition cancer genetic testing
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
This report provides data tables, includes charts and graphs for visual analysis.
Regional Analysis: North America - US - Canada - Mexico
Europe - France - Germany - Italy - Spain - UK - Rest of Europe
Asia Pacific - China - Japan - India - Australia - New Zealand - Rest of Asia
Middle East - Saudi Arabia - UAE - Rest of Middle East
Latin America - Argentina - Brazil - Rest of Latin America
Rest of the World - Africa - Caribbean
Report Highlights: - The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2025 - Market opportunities and recommendations for new investments
Our reports have been used by over 10K customers, including:
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...
The global molecular diagnostics market is projected to grow at a CAGR of 8.4%. The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers,...
236 pages •
By Global Industry Analysts
• Apr 2018
This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific,...
As of 2017, the global genetic testing market was valued at USD 9,367.0 million and is expected to record a CAGR of around 10.4% during 2018-2023 (the forecast period). In 2017, the North American genetic testing segment of the market studied accounted for the highest revenue and Asia-Pacific is expected to register the highest CAGR of 12.6%...
408 pages •
By Global Industry Analysts
• Mar 2018
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is further analyzed by the following Segments: Prenatal & Newborn Genetic Testing, Pharmacogenomic Testing, and Predictive Diagnostics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe,...
140 pages •
By Infiniti Research Limited
• Feb 2018
About Genetic Testing Genetic testing refers to an array of techniques used to analyze nucleic acids such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. The results of the analysis determine the genetic defects caused by hereditary, chronic, and infectious diseases. Genetic testing is a rapidly...